Suitable bone markers assessing bone status in patients with both coronary artery disease and diabetes

Zhila Maghbooli1, Solaleh Emamgholipour2, Arash Hossein-Nezhad3

  • 1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Bone turnover markers osteocalcin (OC) and carboxy-terminal collagen crosslinks (CTX) are lower in coronary artery disease (CAD) patients with type 2 diabetes (T2DM). These markers may be useful for managing CAD patients with diabetes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Bone Metabolism

Background:

  • Coronary artery disease (CAD) and type 2 diabetes (T2DM) are significant health concerns.
  • Investigating bone turnover markers in CAD patients with and without T2DM is crucial for understanding disease interplay.

Purpose of the Study:

  • To compare bone turnover markers (osteocalcin, P1NP, CTX) in CAD patients with and without T2DM.
  • To assess the relationship between bone markers, metabolic factors, and CAD status.

Main Methods:

  • Cross-sectional study of 45 patients undergoing heart surgery.
  • Categorized participants into CAD (n=33) and non-CAD (n=12) groups.
  • Analyzed serum levels of OC, P1NP, CTX, 25(OH) vitamin D3, PTH, and metabolic factors.

Main Results:

  • No significant difference in bone markers between CAD and non-CAD groups.
  • FBG showed an inverse correlation with OC in CAD patients.
  • OC and CTX levels were significantly lower in CAD patients with T2DM compared to those without diabetes.

Conclusions:

  • Osteocalcin (OC) and carboxy-terminal collagen crosslinks (CTX) show potential as bone turnover markers in CAD patients with T2DM.
  • Further research is needed to confirm the clinical utility of these markers in managing diabetes and CAD.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
714
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
697
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
374